KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) EBT Margin (2016 - 2025)

Historic EBT Margin for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to 13.37%.

  • Chemed's EBT Margin fell 33000.0% to 13.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.64%, marking a year-over-year decrease of 19700.0%. This contributed to the annual value of 16.43% for FY2024, which is 9600.0% up from last year.
  • As of Q3 2025, Chemed's EBT Margin stood at 13.37%, which was down 33000.0% from 11.49% recorded in Q2 2025.
  • Over the past 5 years, Chemed's EBT Margin peaked at 19.73% during Q4 2023, and registered a low of 11.49% during Q2 2025.
  • Its 5-year average for EBT Margin is 15.48%, with a median of 15.75% in 2024.
  • Per our database at Business Quant, Chemed's EBT Margin tumbled by -7114400bps in 2021 and then skyrocketed by 46600bps in 2023.
  • Chemed's EBT Margin (Quarter) stood at 17.77% in 2021, then fell by -15bps to 15.07% in 2022, then surged by 31bps to 19.73% in 2023, then dropped by -5bps to 18.77% in 2024, then decreased by -29bps to 13.37% in 2025.
  • Its EBT Margin stands at 13.37% for Q3 2025, versus 11.49% for Q2 2025 and 14.79% for Q1 2025.